Top Markets
Coin of the day
Modalis Therapeutics Corporation Modalis Therapeutics Corporation

Modalis Therapeutics Corporation

4883
Classement en actions #29676
Modalis Therapeutics Corporation focuses on discovering and developing... Modalis Therapeutics Corporation focuses on discovering and developing treatments for severe genetic conditions. The company utilizes its proprietary CRISPR-GNDM technology to create therapies by controlling gene expression through the epigenetic modulation of specific genetic loci. Modalis also has a collaborative research agreement with JCR Pharmaceuticals Co., Ltd., aimed at assessing gene therapy drug delivery methods for the central nervous system (CNS), particularly for CNS-related disorders. Founded in 2016, the company was initially known as EdiGENE Corporation before changing its name to Modalis Therapeutics Corporation in August 2019. Its operations are based in Tokyo, Japan.
Prix de l'action
$0.20877985
Capitalisation boursière
$20.11M
Changement (1 jour)
-3.03%
Changement (1 an)
-66.13%
Pays
JP
Échange Modalis Therapeutics Corporation (4883)

Catégorie

Historique du prix de l'action pour Modalis Therapeutics Corporation (4883)
Prix de clôture le plus élevé : $0.21 le 2026-08-01

Prix de clôture le plus bas : $27.70 le 2020-08-01
Historique du prix de l'action de Modalis Therapeutics Corporation de 2020 à 2026
Performance annuelle du prix de l'action
Année Performance
2026 (TTM) 4.62%
2025 -47.79%
2024 -8.66%
2023 -67.25%
2022 -58.62%
2021 -72.31%
2020 0.00%
Prix de l'action pour des entreprises similaires ou concurrentes
Entreprise Prix de l'action Variation 1a% Pays
$527.89 35.09%
US
$996.61 51.72%
NL
$117.42 -19.34%
AU
$743.14 7.12%
CH
$1.07K -5.58%
KR